A Genetic Triple Play: Adolescent-onset Hyperkinetic Syndrome with Multilocus KMT2B and FGF14 Variants and Familial Hunter Syndrome in One Pedigree

Development of ACP-711, a Selective Modulator of GABA-A Receptor a3, for Essential Tremor: Use of First-in-Human Phase 1 Pharmacokinetics and Pharmacodynamics to Identify Target Dose/Exposure

Hyperkinetic Involuntary Movements as a Manifestation of Chronic Subdural Hematoma: A Systematic Review

Two Cases of Chorea-acanthocytosis (VPS13A Disease)